Digital Therapeutics Market Size, Share & Growth Report 2031
Digital Therapeutics Market Size, Share & Growth Report 2031
Segments - Digital Therapeutics Market by Product Types (Software and Devices), Applications (Obesity, Diabetes, Central Nervous System Disease, Cardio Vascular Diseases, Smoking Cessation, Respiratory Diseases, Gastrointestinal Disorders, and Others), Sales Channels (Business-to-Business and Business-to-Consumers), End-users (Patients, Providers, Payers, Employers, and Others), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecasts, 2023-2031
Upcoming
| Report ID :HC-3953
| 4.3 Rating
| 71 Reviews
| 154 Pages
| Format :
Report Description
The global digital therapeutics market size was valued USD 6.17 Billion in 2022 and is anticipated to reach USD 86.53 Billion by 2031, expanding at a CAGR of 34.1% during the forecast period, 2023 – 2031.
Digital therapeutics is based on evidence therapeutic interference to patients. It is distributed via devices and software programs to manage, protect or handle a medical situation. This software application can be utilized separately or in amalgamation with other medications, devices, or any other therapies to help in health outcomes and patient care. The clinical validation, design, usability, and data security of digital therapeutics are based on technological advancements for best practices.
Digital Therapeutics Market Trends, Drivers, Restraints, and Opportunities
- Digital therapeutics is a recent trend in the fast-growing mobile health space content software programs that mixes medical interference along with digital platforms for diagnosis of conditions or medical disorder, which drives the market.
- Factors such as rising usage of internet and smartphones, digital therapeutics offers primary medical assistance, work in alliance with drug regimens, uses cognitive inducement to connect with wearables, and behavioural changes fuels the market.
- Growing prevalence of geriatric population, chronic diseases, benefits of digital therapeutics, technological advancements, and increasing need to deal rising healthcare expenses are key growth factors spurring the global market.
- The advent of next-generation technologies for instance Artificial Intelligence and IoT these high-tech procedures hold most of the potential to roll out DTx interventions as an additional product which is replacement of conventional therapeutics.
Scope of Digital Therapeutics Market Report
The report on digital therapeutics market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
|
Attributes |
Details |
|
Report Title |
Digital Therapeutics Market – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016-2021 |
|
Forecast Period |
2023-2031 |
|
Segmentation |
Product Types (Software and Devices), Applications (Obesity, Diabetes, Central Nervous System Disease, Cardio Vascular Diseases, Smoking Cessation, Respiratory Diseases, Gastrointestinal Disorders, and Others), Sales Channels (Business-to-Business and Business-to-Consumers), End-users (Patients, Providers, Payers, Employers, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players covered in the Report |
Omada Health Inc., WellDoc Inc., 2Morrow Inc., Livongo Health Inc., Propeller Health, Fitbit Inc., Canary Health, Mango Health, Noom Inc., and Pear Therapeutics |
Digital Therapeutics Market Segment Insights
The software segment accounts for a key market share
Based on product types, the global market is bifurcated into software and devices. The software segment accounts for a key share of the market owing to the increased usage of smartphones and other smart devices. However, the device segment is anticipated to expand at a rapid pace during the forecast period due to increasing customer engagement in devices.
The diabetes segment is estimated to expand at a robust rate
In terms of applications, the market is segregated into obesity, diabetes, central nervous system disease, cardio vascular diseases, smoking cessation, respiratory diseases, gastrointestinal disorders, and others. The diabetes segment is estimated to expand at a robust rate owing to high prevalence of obesity in the countries. Meanwhile, the gastrointestinal disorders provide a high growth rate due to increase in the gastrointestinal cases.
The business-to-consumer’s segment is projected to expand at a considerable CAGR
On the basis of sales channels, the market is bifurcated into business-to-business and business-to-consumers. The business-to-consumers segment is projected to expand at a considerable CAGR owing to rising number of diabetes, high blood pressure, and obesity. On the other hand, the business-to-business segment accounts for a key market share due to rising activities by major market players.
Patient’s segment is attributed to register a high CAGR
Based on end-users, the market is classified into providers, patients, employers, payers, and others. The patient’s segment is attributed to register a high CAGR during the forecast period due to high prevalence of diseases among people. Moreover, the providers segment accounts for a key share of the market due to rising activities by supplier.
Regional Analysis
In terms of regions, the global digital therapeutics market can be split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the market due to the rising use of favourable reimbursement scenarios and digital health products that focus on better quality of life through improved diagnostics & tracking. The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period due to growing demand for personal care devices and related services.
Segments
Product Types
- Software
- Devices
Applications
- Obesity
- Diabetes
- Central Nervous System Disease
- Cardio Vascular Diseases
- Smoking Cessation
- Respiratory Diseases
- Gastrointestinal Disorders
- Others
Sales Channels
- Business-to-Business
- Business-to-Consumers
Regions
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East & Africa
Key Players
- Omada Health, Inc.
- WellDoc, Inc.
- 2Morrow, Inc.
- Livongo Health, Inc.
- Propeller Health
- Fitbit Inc.
- Canary Health
- Mango Health
- Noom, Inc.
- Pear Therapeutics
Competitive Landscape
Key players in the digital therapeutics market include Omada Health, Inc., WellDoc, Inc., 2Morrow, Inc., Livongo Health, Inc., Propeller Health, Fitbit Inc., Canary Health, Mango Health, Noom, Inc., and Pear Therapeutics. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Digital Therapeutics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Digital Therapeutics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Digital Therapeutics Market - Supply Chain
4.5. Global Digital Therapeutics Market Forecast
4.5.1. Digital Therapeutics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Digital Therapeutics Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Digital Therapeutics Market Absolute $ Opportunity
5. Global Digital Therapeutics Market Analysis and Forecast by Region
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Region
5.2.2. Y-o-Y Growth Projections by Region
5.3. Digital Therapeutics Market Size and Volume Forecast by Region
5.3.1. North America
5.3.2. Latin America
5.3.3. Europe
5.3.4. Asia Pacific
5.3.5. Middle East and Africa (MEA)
5.4. Absolute $ Opportunity Assessment by Region
5.5. Market Attractiveness/Growth Potential Analysis by Region
5.6. Global Digital Therapeutics Demand Share Forecast, 2019-2026
6. North America Digital Therapeutics Market Analysis and Forecast
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis by Country
6.1.2. Y-o-Y Growth Projections by Country
6.2. North America Digital Therapeutics Market Size and Volume Forecast by Country
6.2.1. U.S.
6.2.2. Canada
6.3. Absolute $ Opportunity Assessment by Country
6.4. Market Attractiveness/Growth Potential Analysis
6.4.1. By Country
6.4.2. By Product Type
6.4.3. By Application
6.5. North America Digital Therapeutics Demand Share Forecast, 2019-2026
7. Latin America Digital Therapeutics Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.1.3. Latin America Average Pricing Analysis
7.2. Latin America Digital Therapeutics Market Size and Volume Forecast by Country
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Absolute $ Opportunity Assessment by Country
7.4. Market Attractiveness/Growth Potential Analysis
7.4.1. By Country
7.4.2. By Product Type
7.4.3. By Application
7.5. Latin America Digital Therapeutics Demand Share Forecast, 2019-2026
8. Europe Digital Therapeutics Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Europe Average Pricing Analysis
8.2. Europe Digital Therapeutics Market Size and Volume Forecast by Country
8.2.1. Germany
8.2.2. France
8.2.3. Italy
8.2.4. U.K.
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Absolute $ Opportunity Assessment by Country
8.4. Market Attractiveness/Growth Potential Analysis
8.4.1. By Country
8.4.2. By Product Type
8.4.3. By Application
8.5. Europe Digital Therapeutics Demand Share Forecast, 2019-2026
9. Asia Pacific Digital Therapeutics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Asia Pacific Average Pricing Analysis
9.2. Asia Pacific Digital Therapeutics Market Size and Volume Forecast by Country
9.2.1. China
9.2.2. Japan
9.2.3. South Korea
9.2.4. India
9.2.5. Australia
9.2.6. Rest of Asia Pacific (APAC)
9.3. Absolute $ Opportunity Assessment by Country
9.4. Market Attractiveness/Growth Potential Analysis
9.4.1. By Country
9.4.2. By Product Type
9.4.3. By Application
9.5. Asia Pacific Digital Therapeutics Demand Share Forecast, 2019-2026
10. Middle East & Africa Digital Therapeutics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Middle East & Africa Average Pricing Analysis
10.2. Middle East & Africa Digital Therapeutics Market Size and Volume Forecast by Country
10.2.1. Saudi Arabia
10.2.2. South Africa
10.2.3. UAE
10.2.4. Rest of Middle East & Africa (MEA)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Market Attractiveness/Growth Potential Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By Application
10.5. Middle East & Africa Digital Therapeutics Demand Share Forecast, 2019-2026
11. Competition Landscape
11.1. Global Digital Therapeutics Market: Market Share Analysis
11.2. Digital Therapeutics Distributors and Customers
11.3. Digital Therapeutics Market: Competitive Dashboard
11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
11.4.1. Omada Health, Inc.
11.4.2. WellDoc, Inc.
11.4.3. 2Morrow, Inc.
11.4.4. Livongo Health, Inc.
11.4.5. Propeller Health
11.4.6. Fitbit Inc.
11.4.7. Canary Health
11.4.8. Mango Health
Methodology
Related Reports
Some other reports from this category!
Our Clients
